Latest Regenerative Neurology News

Researchers have seen good success in animal studies, and are advancing to the first clinical trials in humans. What a time to be alive.
Indiana University’s new MAP-AD center will use stem-cell-derived brain models and AI to advance Alzheimer’s research and drug development.
Klotho Neurosciences expands into cellular reprogramming with a planned Turn Biotechnologies acquisition and significant pharma partnership.
The Chinese biotech company shared promising preclinical and early clinical results for its novel ALS therapy
Aspen’s trial advances with a commercial-ready, patient-derived cell therapy aiming to improve Parkinson’s outcomes and streamline clinical delivery.
The exPDite-2 trial will evaluate the safety and effectiveness of donor-derived stem cell therapy in Parkinson’s disease patients.
Australian urologists can now access Remplir to support nerve protection and recovery during robotic prostate cancer surgeries.
The trial will inject autologous stem cells directly into the brain to bypass the blood-brain-barrier.
A new clinical trial in Texas will evaluate stem cell therapy’s potential to improve outcomes for adults with chronic TBI.
The first use of silk-based SilkAxonsâ„¢ aims to address large peripheral nerve injuries where current treatments fall short.

Stay updated on Regenerative Medicine